Advertisement Clinical Trial Supply Case Studies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Penn Pharma

Drug Development, Clinical Supplies & Contract Manufacturing Solutions

More info about Penn Pharma

Clinical Trial Supply Case Studies

CASE STUDIES
By Penn Pharma

Virtual Pharma Company, Large Pharma - IMP Supply Project and fast track clinical trial supply case studies.

Client: Virtual Pharma Company

Challenge:

  • Problematic formulation and analytical method
  • Blinding issues with market leading comparator

Penn solution/ongoing support:

  • Developed a suitable manufacturing process and re-built the analytical method
  • Over-encapsulated market leading comparator and developed the analytical method to general appropriate stability data
  • Support for three simultaneous phase III trials
  • Average of 1,800 patients per trial
  • Multi national trial – EU, US and ROW
  • 64,000 monthly kits over two years
  • Bespoke child resistant – senior friendly (CRSF) packaging solution
  • Liaise with two CROs
  • Liaise with two IVRS providers
  • Penn arranged multiple global distribution depots

Client: Large Pharma – IMP Supply Project

Challenge:

  • Each patient pack contained four products – 16 vials
  • Multinational trial – US, EU and ROW
  • Supplies despatched at 2°C-8°C to countries with varying external ambient temperatures

Penn solution/ongoing support:

  • Bespoke packaging configuration
  • Multiple global distribution depots
  • Use of specialist courier
  • Use of PDF data logger with programmable alarm

Fast track CTS case studies

Phase I dose escalation

  • Dose escalation study required extra cohort of 16 patients urgently to complete study
  • Monday: Teleconference with client
  • Tuesday: Prepare and approve documents for label text
  • Wednesday: Product labels, receive product from manufacturer
  • Thursday: Pack, release and distribute product

Phase I toxic compound

  • Required 20 patient kits packed and shipped at -20°C – highly toxic compound
  • Product could only remain out of freezer for maximum of five minutes
  • IMP packed by team in walk-in freezer
  • Classified as dangerous goods i.e. special pack and shipping conditions
  • Shipped successfully to site in Estonia on time

Blinded complex study

  • Nine drug materials, seven table strengths + active and placebo auto-injectors
  • Innovative approach to labelling to ensure injector remained blinded after firing
  • Tables shipped refrigerated due to stability issues
  • Short timescales
  • Project completed successfully and on time